Granule exocytosis and neutrophil activation
Granule exocytosis and neutrophil activation
批准号:
7589011
负责人:
Silvia M Uriarte
金额:
$12.91万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-03-01 至 2011-02-28
关键词:
AcuteAcute Lung InjuryAddressAdherenceAirAnimal ModelArtsC-terminalCell membraneCellular biologyChemotaxisChimeric ProteinsCoiled-Coil DomainComputer softwareCytoplasmic GranulesDataDatabasesDockingEventExocytosisFundingGelatinasesGenerationsGoalsHumanImmunoprecipitationInflammationInflammatory ResponseIntracellular MembranesLearningMass Spectrum AnalysisMediatingMembraneMembrane FusionMembrane Protein TrafficMentorsMethodologyModelingMolecularMolecular BiologyN-terminalNatural ImmunityNeutrophil ActivationNormal tissue morphologyPeptide HydrolasesPeptidesPhagocytosisPhasePhosphorylationPlasmidsPost-Translational Protein ProcessingProteinsProteomicsRattusReactive Oxygen SpeciesRegulationResearch PersonnelRespiratory BurstRoleSNAP receptorSecretory VesiclesSiteState InterestsStimulusTechniquesTechnologyTertiary Protein StructureTestingTissuesTrainingVesicleabstractingbaseeffusionexperienceextracellularin vitro testingin vivokillingsneutrophilnovel strategiespreventreceptorresponseskillssyntaxin
中文摘要
描述(由申请人提供):
胞吐作用在介导与中性粒细胞活化相关的各种功能反应中的假定作用尚未直接测试。我们将使用一种新的方法;产生TAT融合蛋白,其含有不同SNARE蛋白的卷曲螺旋结构域;以测试以下假设:阻断不同颗粒亚群的胞吐作用将防止特定的中性粒细胞表型变化,并且这种策略可用于防止嗜中性粒细胞介导的体内组织损伤。该建议的指导阶段的具体目标是:1)确定含有SNAP-23的SNARE结构域、突触融合蛋白和VAMP的TAT融合蛋白抑制四种中性粒细胞颗粒亚群中的每一种的胞吐作用的能力。该目标的培训目标是发展分子生物学和细胞生物学技能,使申请人能够在新的水平上解决实验问题,并将其应用于本提案的独立阶段。2)确定TAT-SNARE融合蛋白体内给药的最有效方式,并确定这些融合蛋白对大鼠急性嗜酸性粒细胞依赖性炎症模型的影响。该目标的训练目标是学习嗜中性粒细胞依赖性炎症的动物模型,并建立TAT融合蛋白在体内抑制嗜中性粒细胞胞吐的能力。3)通过蛋白质组学分析确定与SNARE蛋白相互作用的其他蛋白质。该目标的培训目标是培养进行蛋白质组学分析的能力。在指导阶段获得的最新技术将大大提高专业知识,使PI成为一名成功的独立研究者。对于独立阶段,具体目标是:1)确定由中性粒细胞胞吐调节的特异性功能反应; 2)确定体内抑制中性粒细胞胞吐阻断炎症反应的机制; 3)研究刺激胞吐的分子机制。申请人将接受的培训将使她在经验,兴趣和最先进的技术相结合方面独一无二,并将最大限度地发挥她成为独立NIH资助研究者的潜力。(End摘要)
英文摘要
DESCRIPTION (provided by applicant):
The postulated role of exocytosis in mediating various functional responses associated with neutrophil activation has not been directly tested. We will use a novel approach; generating TAT-fusion proteins containing the coiled-coil domains of different SNARE proteins; to test the hypothesis that blocking exocytosis of distinct granule subsets will prevent specific neutrophil phenotypic changes and this strategy may be used to prevent neutrophil-mediated tissue damage in vivo. The specific objectives of the mentored phase of this proposal are: 1) to determine the ability of TAT-fusion proteins containing the SNARE domains of SNAP-23, syntaxins, and VAMPs to inhibit exocytosis of each of the four neutrophil granule subsets. The training goal of this aim is to develop molecular biology and cell biology skills that will allow the applicant to address experimental questions at new levels and apply them in the independent phase of this proposal. 2) To determine the most effective way to administer the TAT-SNARE fusion proteins in vivo and to determine the effect of these fusion proteins on models of acute neutrophil-dependent inflammation in rats. The training goals of this aim are to learn animal models of neutrophil-dependent inflammation, and to establish the ability of TAT-fusion proteins to inhibit neutrophil exocytosis in vivo. 3) Define other proteins that interact with SNARE proteins by proteomic analysis. The training goal of this aim is to develop the ability to perform proteomic analysis. The state-of-the-art techniques acquired during the mentored phase will greatly increase the expertise that will allow the PI to become a successful independent investigator. For the independent phase the specific objectives are: 1) To determine the specific functional responses that are regulated by neutrophil granule exocytosis; 2) To define the mechanisms by which inhibition of neutrophil exocytosis in vivo blocks the inflammatory response; and 3) To investigate the molecular mechanisms by which exocytosis is stimulated. The training the applicant will receive will make her unique in the combination of experience, interest, and state-of-the-art technology and will maximize her potential to become an independent NIH-funded investigator. (End of Abstract)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Filifactor alocis interactions with neutrophils
-
批准号:10689252
-
项目类别:
-
资助金额:$44.92万
-
财政年份:2014
-
负责人:Silvia M Uriarte
-
依托单位:
Filifactor alocis interactions with neutrophils
-
批准号:9024353
-
项目类别:
-
资助金额:$37.34万
-
财政年份:2014
-
负责人:Silvia M Uriarte
-
依托单位:
Filifactor alocis interactions with neutrophils
-
批准号:8747218
-
项目类别:
-
资助金额:$36.65万
-
财政年份:2014
-
负责人:Silvia M Uriarte
-
依托单位:
Filifactor alocis interactions with neutrophils
-
批准号:10458581
-
项目类别:
-
资助金额:$45.41万
-
财政年份:2014
-
负责人:Silvia M Uriarte
-
依托单位:
Filifactor alocis interactions with neutrophils
-
批准号:10017946
-
项目类别:
-
资助金额:$47.53万
-
财政年份:2014
-
负责人:Silvia M Uriarte
-
依托单位:
Filifactor alocis interactions with neutrophils
-
批准号:10231153
-
项目类别:
-
资助金额:$46.66万
-
财政年份:2014
-
负责人:Silvia M Uriarte
-
依托单位:
Granule exocytosis and neutrophil activation
-
批准号:8324192
-
项目类别:
-
资助金额:$24.39万
-
财政年份:2011
-
负责人:Silvia M Uriarte
-
依托单位:
Granule exocytosis and neutrophil activation
-
批准号:8528689
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2011
-
负责人:Silvia M Uriarte
-
依托单位:
Granule exocytosis and neutrophil activation
-
批准号:8310566
-
项目类别:
-
资助金额:$24.61万
-
财政年份:2011
-
负责人:Silvia M Uriarte
-
依托单位:
海外基金